Myelodysplastic syndromes and acute myeloid leukemia. Diagnostic criteria and pitfalls
Farhi, D.C.
Pathology Annual 30: 29-57
1995
ISSN/ISBN: 0079-0184 PMID: 7731744 Document Number: 449663
Document emailed within 1 workday
Related Documents
Steensma, D.P. 2007: The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia Haematologica 92(6): 723-727Xu, K.; Wang, L.; Hao, Y.; Shao, Z.; Meng, Q.; Li, K.; Chao, H.; Tang, K.; Wang, L. 1999: Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia Chinese Medical Journal 112(12): 1112-1118
Lai, J.L.; Preudhomme, C.; Zandecki, M.; Flactif, M.; Vanrumbeke, M.; Lepelley, P.; Wattel, E.; Fenaux, P. 1995: Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations Leukemia 9(3): 370-381
Bernell, P.; Kimby, E.; Hast, R. 1994: Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study Leukemia 8(10): 1631-1639
Pinto, A.; Zagonel, V.; Attadia, V.; Bullian, P.L.; Gattei, V.; Carbone, A.; Monfardini, S.; Colombatti, A. 1989: 5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly Bone Marrow Transplantation 4(Suppl): 28-32
Fenaux, P.; Collyn d'Hooghe, M.; Jonveaux, P.; Lai, J.L.; Bauters, F.; Loucheux, M.H.; Kerckaert, J.P. 1990: Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 341-344
Xie, J.; Briggs, J.A.; Morris, S.W.; Olson, M.O.; Kinney, M.C.; Briggs, R.C. 1997: MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia Experimental Hematology 25(11): 1111-1117
Cheson, B.D.; Simon, R. 1987: Low-dose ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a review of 20 years' experience Seminars in Oncology 14(2 Suppl 1: 126-133
Cortes, J.E.; Kantarjian, H.; O'Brien, S.; Keating, M.; Pierce, S.; Freireich, E.J.; Estey, E. 1995: Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes Leukemia 9(1): 115-117
Nasu, H.; Hibi, N.; Ohyashiki, J.H.; Hara, A.; Kubono, K.; Tsukada, Y.; Ando, K.; Iwama, H.; Hayashi, S.; Yahata, N.; Toyama, K.; Ohyashiki, K. 1998: Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes International Journal of Oncology 13(3): 525-530
Barnard, D.R.; Kalousek, D.K.; Wiersma, S.R.; Lange, B.J.; Benjamin, D.R.; Arthur, D.C.; Buckley, J.D.; Kobrinsky, N.; Neudorf, S.; Sanders, J.; Miller, L.P.; Shina, D.C.; Hammond, G.D.; Woods, W.G. 1996: Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group Leukemia 10(1): 5-12
Shen, Y.; Xue, Y.; Li, J.; Pan, J.; Wu, Y. 2003: Clinical, cytogenetic and dual-color FISH studies on five cases of myelodysplastic syndrome or acute myeloid leukemia patients with 1;7 translocation Chinese Medical Journal 116(2): 231-234
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Ducastelle, S.; Adès, L.; Gardin, C.; Dombret, Hé.; Prébet, T.; Deconinck, E.; Rio, B.; Thomas, X.; Debotton, S.; Guerci, Aès.; Gratecos, N.; Stamatoullas, A.; Fegueux, N.; Dreyfus, Fçois.; Fenaux, P.; Wattel, E. 2006: Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia Haematologica 91(3): 373-376
Januszewicz, E.H.; Firkin, F.C. 1988: Differentiation in acute myeloid leukemia and myelodysplastic disorders. Is differentiation-induction therapy possible? Australian and New Zealand Journal of Medicine 18(5): 705-711
Gaĭdukova, S.N.; Guseva, S.A.; Tishchenko, L.M. 1989: Differential diagnostic criteria of blast cells in the peripheral blood in acute myeloid leukemias Vrachebnoe Delo 1989(9): 38-41
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Ishikawa, M.; Nakayama, K.; Rahman, M.T.; Rahman, M.; Katagiri, H.; Katagiri, A.; Ishibashi, T.; Iida, K.; Nakayama, N.; Miyazaki, K. 2014: Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report European Journal of Gynaecological Oncology 35(4): 443-448
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334